Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT as a function of ALC recovery at day 15.

Median overall survival time for patients with an ALC less than 500 cells/μL was 6 months. For patients with an ALC greater than or equal to 500 cells/μL, the median overall survival has not been reached (P < .0001).